Selected article for: "acutely medical and low molecular weight heparin"
Author: Marietta, Marco; Coluccio, Valeria; Luppi, Mario
Title: More on: ‘COVID‐19 coagulopathy in Caucasian patients’
  • Cord-id: ajezk7kr
  • Document date: 2020_5_22
    • ID: ajezk7kr
    Snippet: We read with interest the report from Fogarty and colleagues about COVID-19 coagulopathy in Caucasian patients. [1] However, we think that some aspects of this report may deserve further attention. The major concern regards the doses of low-molecular weight heparin (LMWH) used for thromboprophylaxis in this study. Indeed, the Authors report on a weight-adjusted dose of enoxaparin higher than that registered in Europe for the prophylaxis of venous thromboembolism (VTE) in hospitalized acutely ill
    Document: We read with interest the report from Fogarty and colleagues about COVID-19 coagulopathy in Caucasian patients. [1] However, we think that some aspects of this report may deserve further attention. The major concern regards the doses of low-molecular weight heparin (LMWH) used for thromboprophylaxis in this study. Indeed, the Authors report on a weight-adjusted dose of enoxaparin higher than that registered in Europe for the prophylaxis of venous thromboembolism (VTE) in hospitalized acutely ill medical patients.

    Search related documents:
    Co phrase search for related documents
    • acute respiratory distress syndrome and lmwh low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute respiratory distress syndrome and low molecular: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • acute respiratory distress syndrome and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • acutely ill and lmwh low molecular weight heparin: 1, 2
    • acutely ill and lmwh low molecular weight heparin dose: 1, 2
    • acutely ill and low molecular: 1, 2, 3, 4
    • acutely ill and low molecular weight: 1, 2, 3, 4
    • acutely ill and low molecular weight heparin: 1, 2, 3, 4
    • adjustment dose and lmwh low molecular weight heparin: 1
    • adjustment dose and low molecular: 1, 2, 3, 4
    • adjustment dose and low molecular weight: 1, 2, 3
    • adjustment dose and low molecular weight heparin: 1, 2, 3
    • lmwh low molecular weight heparin and low molecular: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • lmwh low molecular weight heparin and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • lmwh low molecular weight heparin and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • lmwh low molecular weight heparin dose and low molecular: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • lmwh low molecular weight heparin dose and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18